Chanticleer Holdings, Inc. (30) | Business Finance (15)

Browse by Subcategory

Recent Contracts

Form of Sonnet BioTherapeutics, Inc. Converted Warrant (Filed With SEC on August 14, 2020)
Form of Restricted Stock Unit Award (Filed With SEC on July 9, 2020)
Share Exchange Agreement, between Sonnet BioTherapeutics, Inc. and Relief Therapeutics Holding SA, dated August 9, 2019 (Filed With SEC on November 27, 2019)
Form of Escrow Agreement (Filed With SEC on May 28, 2019)
Form of Subscription Rights Certificate (Filed With SEC on May 28, 2019)
Amendment to 6% Secured Subordinated Convertible Note by and between the Company and certain note holder (Filed With SEC on April 1, 2019)
Amendment to 8% Secured Debentures by and between the Company and Debenture Holders (Filed With SEC on April 1, 2019)
Form of Series C Warrant (Filed With SEC on August 4, 2020)
Form of Warrant Exercise and Omnibus Amendment Agreement, dated as of August 3, 2020, by and between Sonnet BioTherapeutics Holdings, Inc. and the Holders (Filed With SEC on August 4, 2020)
Spin-Off Entity Warrant, dated April 1, 2020 (Filed With SEC on April 3, 2020)
Common Stock Purchase Agreement, between GEM Global Yield Fund LLC SCS and Sonnet BioTherapeutics, Inc., dated August 6, 2019 (Filed With SEC on November 27, 2019)
Amendment to Common Stock Purchase Agreement, between GEM Global Yield Fund LLC SCS and Sonnet BioTherapeutics, Inc., dated September 25, 2019 (Filed With SEC on November 27, 2019)
Amendment to Warrant dated May 15, 2019 by and between Chanticleer Holdings, Inc. and Larry Steven Spitcaufsky TTEE Larry S Spitcaufsky Family Trust U/A DTD 08/23/1995 (Filed With SEC on May 20, 2019)
Amendment to Warrant dated May 15, 2019 by and between Chanticleer Holdings, Inc. and Larry Steven Spitcaufsky Charles Schwab & Co Inc Cust Roth Contributory IRA (Filed With SEC on May 20, 2019)
Restricted Stock Unit Award Agreement dated November 16, 2018 by and between the Company and Frederick L. Glick (Filed With SEC on April 1, 2019)